These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21521571)

  • 21. [72-year-old patient with tumor and gastrointestinal bleeding].
    Gerber T
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1123-4. PubMed ID: 20503138
    [No Abstract]   [Full Text] [Related]  

  • 22. Zenker's diverticulitis secondary to alendronate ingestion: a rare cause of recurrent dysphagia.
    Sharma R; DeCross AJ
    Gastrointest Endosc; 2011 Feb; 73(2):368-70. PubMed ID: 21295647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alendronate for treatment of osteoporoses].
    Harada A
    Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium polystyrene sulfonate-induced esophageal ulcer.
    Brown R; Samuel J; Parmar K; Shuja S; deMelo SW
    Gastrointest Endosc; 2016 Mar; 83(3):664; discussion 664-5. PubMed ID: 26422977
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G
    Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reliably combined to combat osteoporosis].
    MMW Fortschr Med; 2005 Dec; 147(51-52):63. PubMed ID: 16402714
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metronidazole-induced esophageal ulcer. A case report].
    Marín Pineda R; Vila G
    Rev Gastroenterol Mex; 1998; 63(2):106-7. PubMed ID: 10068738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP
    Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of esophageal perforation due to a pill-induced ulcer successfully treated with conservative measures.
    Yamaoka K; Takenawa H; Tajiri K; Yamane M; Kadowaki K; Marumo F; Sato C
    Am J Gastroenterol; 1996 May; 91(5):1044-5. PubMed ID: 8633552
    [No Abstract]   [Full Text] [Related]  

  • 32. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
    Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
    Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe, long-lasting symptoms from doxycycline-induced esophageal injury.
    Tankurt IE; Akbaylar H; Yenicerioglu Y; Simsek I; Gonen O
    Endoscopy; 1995 Oct; 27(8):626. PubMed ID: 8608761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bisphosphonates for osteoporosis].
    Narusawa K; Nakamura T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():311-5. PubMed ID: 18161123
    [No Abstract]   [Full Text] [Related]  

  • 36. Pill-induced esophageal ulcer.
    Yap I; Guan R; Kang JY; Gwee KA; Tan CC
    Singapore Med J; 1993 Jun; 34(3):257-8. PubMed ID: 8266186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ulcer of the esophagus after intake of emeproniumbromide (author's transl)].
    Berges W; Rohner HG; Wienbeck W
    Leber Magen Darm; 1980 Feb; 10(1):37-40. PubMed ID: 7374325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate.
    Marshall JK; Thabane M; James C
    Dig Dis Sci; 2006 May; 51(5):864-8. PubMed ID: 16642421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil-induced esophageal ulcers.
    Higuchi K; Ando K; Kim SR; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Oshitani N; Matsumoto T; Arakawa T
    Am J Gastroenterol; 2001 Aug; 96(8):2516-8. PubMed ID: 11513213
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.